Cargando…
Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
BACKGROUND: This study aimed to evaluate clinical, laboratory, ultrasound (US) and scintigraphyc parameters in thyroid nodule and to develop an auxiliary model for clinical application in the diagnosis of malignancy. METHODS: We assessed 143 patients who were surgically treated at a single center, 6...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073950/ https://www.ncbi.nlm.nih.gov/pubmed/21426548 http://dx.doi.org/10.1186/1758-3284-3-17 |
_version_ | 1782201668753948672 |
---|---|
author | Maia, Frederico FR Matos, Patrícia S Silva, Bradley P Pallone, Ana T Pavin, Elizabeth J Vassallo, José Zantut-Wittmann, Denise E |
author_facet | Maia, Frederico FR Matos, Patrícia S Silva, Bradley P Pallone, Ana T Pavin, Elizabeth J Vassallo, José Zantut-Wittmann, Denise E |
author_sort | Maia, Frederico FR |
collection | PubMed |
description | BACKGROUND: This study aimed to evaluate clinical, laboratory, ultrasound (US) and scintigraphyc parameters in thyroid nodule and to develop an auxiliary model for clinical application in the diagnosis of malignancy. METHODS: We assessed 143 patients who were surgically treated at a single center, 65% (93) benign vs. 35% (50) malignant lesions at final histology (1998-2008). The clinical, laboratory, scintigraphyc and US features were compared and a prediction model was designed after the multivariate analysis. RESULTS: There were no differences in gender, serum TSH and FT4 levels, thyroid auto-antibodies (TAb), thyroid dysfunction and scintigraphyc results (P = 0.33) between benign and malignant nodule groups. The sonographic study showed differences when the presence of suspected characteristics was found in the nodules of the malignant lesions group, such as: microcalcifications, central flow, border irregularity and hypoechogenicity. After the multivariate analysis the model obtained showed age (>39 years), border irregularity, microcalcifications and nodule size over 2 cm as predictive factors of malignancy, featuring 81.7% of accuracy. CONCLUSIONS: This study confirmed a significant increase of risk for malignancy in patients of over 39 years and with suspicious features at US. |
format | Text |
id | pubmed-3073950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30739502011-04-12 Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule Maia, Frederico FR Matos, Patrícia S Silva, Bradley P Pallone, Ana T Pavin, Elizabeth J Vassallo, José Zantut-Wittmann, Denise E Head Neck Oncol Research BACKGROUND: This study aimed to evaluate clinical, laboratory, ultrasound (US) and scintigraphyc parameters in thyroid nodule and to develop an auxiliary model for clinical application in the diagnosis of malignancy. METHODS: We assessed 143 patients who were surgically treated at a single center, 65% (93) benign vs. 35% (50) malignant lesions at final histology (1998-2008). The clinical, laboratory, scintigraphyc and US features were compared and a prediction model was designed after the multivariate analysis. RESULTS: There were no differences in gender, serum TSH and FT4 levels, thyroid auto-antibodies (TAb), thyroid dysfunction and scintigraphyc results (P = 0.33) between benign and malignant nodule groups. The sonographic study showed differences when the presence of suspected characteristics was found in the nodules of the malignant lesions group, such as: microcalcifications, central flow, border irregularity and hypoechogenicity. After the multivariate analysis the model obtained showed age (>39 years), border irregularity, microcalcifications and nodule size over 2 cm as predictive factors of malignancy, featuring 81.7% of accuracy. CONCLUSIONS: This study confirmed a significant increase of risk for malignancy in patients of over 39 years and with suspicious features at US. BioMed Central 2011-03-22 /pmc/articles/PMC3073950/ /pubmed/21426548 http://dx.doi.org/10.1186/1758-3284-3-17 Text en Copyright ©2011 Maia et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Maia, Frederico FR Matos, Patrícia S Silva, Bradley P Pallone, Ana T Pavin, Elizabeth J Vassallo, José Zantut-Wittmann, Denise E Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule |
title | Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule |
title_full | Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule |
title_fullStr | Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule |
title_full_unstemmed | Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule |
title_short | Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule |
title_sort | role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073950/ https://www.ncbi.nlm.nih.gov/pubmed/21426548 http://dx.doi.org/10.1186/1758-3284-3-17 |
work_keys_str_mv | AT maiafredericofr roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule AT matospatricias roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule AT silvabradleyp roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule AT palloneanat roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule AT pavinelizabethj roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule AT vassallojose roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule AT zantutwittmanndenisee roleofultrasoundclinicalandscintigraphycparameterstopredictmalignancyinthyroidnodule |